Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity
Withdrawn
- Conditions
- Prostate Cancer
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- DiaCarta, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT04580667
- Locations
- 🇺🇸
University of Florida, Gainesville, FL, Gainesville, Florida, United States
🇺🇸UF Health Proton Therapy Institute, Jacksonville, Florida, United States
🇺🇸NY Cancer and Blood Specialists, The Bronx, New York, United States
News
No news found